BIOMAT Database Logo BIOMAT Database Logo

MALDI-imaging: what can be expected? 2012

Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
Core Unit Chip Application (CUCA), Institute of Human Genetics, Jena University Hospital, Leutragraben 3, Jena, Germany. fegg@mti.uni-jena.de

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003936 Diagnosis, Computer-Assisted Application of computer programs designed to assist the physician in solving a diagnostic problem. Computer-Assisted Diagnosis,Computer Assisted Diagnosis,Computer-Assisted Diagnoses,Diagnoses, Computer-Assisted,Diagnosis, Computer Assisted
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D057054 Molecular Imaging The use of molecularly targeted imaging probes to localize and/or monitor biochemical and cellular processes via various imaging modalities that include RADIONUCLIDE IMAGING; ULTRASONOGRAPHY; MAGNETIC RESONANCE IMAGING; FLUORESCENCE IMAGING; and MICROSCOPY. Imaging, Molecular
D019032 Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization A mass spectrometric technique that is used for the analysis of large biomolecules. Analyte molecules are embedded in an excess matrix of small organic molecules that show a high resonant absorption at the laser wavelength used. The matrix absorbs the laser energy, thus inducing a soft disintegration of the sample-matrix mixture into free (gas phase) matrix and analyte molecules and molecular ions. In general, only molecular ions of the analyte molecules are produced, and almost no fragmentation occurs. This makes the method well suited for molecular weight determinations and mixture analysis. Laser Desorption-Ionization Mass Spectrometry, Matrix-Assisted,MALD-MS,MALDI,Mass Spectrometry, Matrix-Assisted Laser Desorption-Ionization,Mass Spectroscopy, Matrix-Assisted Laser Desorption-Ionization,Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry,Spectroscopy, Mass, Matrix-Assisted Laser Desorption-Ionization,MALDI-MS,MS-MALD,SELDI-TOF-MS,Surface Enhanced Laser Desorption Ionization Mass Spectrometry,Laser Desorption Ionization Mass Spectrometry, Matrix Assisted,MALDI MS,Mass Spectrometry, Matrix Assisted Laser Desorption Ionization,Mass Spectroscopy, Matrix Assisted Laser Desorption Ionization,Matrix Assisted Laser Desorption Ionization Mass Spectrometry

Related Publications

Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
[Liposuction. What results can be expected?].
March 1992, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
[What can be expected from thermography?].
January 1971, Archives d'ophtalmologie et revue generale d'ophtalmologie,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
[Anti-tau therapies-what can be expected?]
September 2019, Der Nervenarzt,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
[What can be expected from chronic hemodialysis?].
September 1976, Revue medicale de la Suisse romande,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
[What can be expected of ocular fluoroangiography?].
March 1972, Therapeutische Umschau. Revue therapeutique,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
[What can be expected of family planning?].
April 1989, Imbonezamuryango = Famille, sante, developpement,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
[What can be expected of rubella serodiagnosis?].
June 1984, Annales de pediatrie,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
[What can be expected of intracavernous injections?].
January 1988, Acta urologica Belgica,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
Teaching pharmacology--what should be taught, what results can be expected?
March 2003, International journal of clinical pharmacology and therapeutics,
Ferdinand von Eggeling, and Anna C Crecelius, and Ulrich S Schubert, and Orlando Guntinas-Lichius, and Güunther Ernst
Ocular manifestation of primary nervous system lymphoma: what can be expected from imaging?
December 2002, Journal of neurology,
Copied contents to your clipboard!